Foster Dykema Cabot & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Foster Dykema Cabot & Co’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,100	Closed	-$126K	–	110
2016 Q4	$126K	Hold	10,100	–	–	0.02%	107
2016 Q3	$138K	Hold	10,100	–	–	0.03%	111
2016 Q2	$75K	Sell	10,100 -100	-1%	-$750	0.02%	89
2016 Q1	$65K	Hold	10,200	–	–	0.02%	87
2015 Q4	$64K	Hold	10,200	–	–	0.02%	86
2015 Q3	$60K	Hold	10,200	–	–	0.02%	87
2015 Q2	$84K	Hold	10,200	–	–	0.02%	89
2015 Q1	$84K	Hold	10,200	–	–	0.02%	88
2014 Q4	$70K	Hold	10,200	–	–	0.02%	91
2014 Q3	$55K	Hold	10,200	–	–	0.01%	91
2014 Q2	$65K	Hold	10,200	–	–	0.02%	88
2014 Q1	$82K	Hold	10,200	–	–	0.02%	85
2013 Q4	$70K	Hold	10,200	–	–	0.02%	91
2013 Q3	$188K	Hold	10,200	–	–	0.05%	88
2013 Q2	$178K	Buy	+10,200	New	+$181K	0.05%	79

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Foster Dykema Cabot & Co's ARIA Position: Q1 2017 in Review

Foster Dykema Cabot & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 10,100 shares — an estimated $126K sold.

Foster Dykema Cabot & Co first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $188K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Foster Dykema Cabot & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Foster Dykema Cabot & Co sold 10,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $126K.
Foster Dykema Cabot & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Foster Dykema Cabot & Co's Ariad Pharmaceuticals Inc position peaked at $188K in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Foster Dykema Cabot & Co's 13F filing for Q1 2017, filed 10 May 2017.